Latest News

PARP inhibitor becomes new treatment option for some men with advanced prostate cancer

Results from an international clinical trial found that men with advanced prostate cancer who have mutated BRCA1/BRCA2 genes can be treated successfully with a targeted therapy known as rucaparib, resulting in recent FDA approval.

Source link

Related posts



A RAVE investigation on Galactic open clusters I. Radial velocities and metallicities


Want To Feel Younger? Take Control And Exercise More, Research Says


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World